Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)

Clinical trial NCT03624881 · COMPLETED

Trial details

NCT number: NCT03624881
Sponsor: Biosense Webster, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Paroxysmal Atrial Fibrillation

Start date: 2018-09-04
Primary completion: 2021-06-28
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.